Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Remon

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2017
A step towards the harmonization of clinical trials inform consent formsJ Remon, C Ferté
Frontiers in Oncology|April 27, 2018
Brain Metastases in Oncogene-Addicted Non-Small Cell Lung Cancer Patients: Incidence and TreatmentJ Remon, Benjamin Besse
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 21, 2017
Improving brain penetration of kinase inhibitors in lung cancer patients with oncogene dependencyJ Remon, J C Soria
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 24, 2025
Telisotuzumab vedotin and osimertinib: the METamorphosis of epidermal growth factor receptor-mutant lung cancer?J Remon, S P L Saw
Cancer Treatment Reviews|February 18, 2018
Immune checkpoint inhibitors in non-small cell lung cancer (NSCLC): Approaches on special subgroups and unresolved burning questionsJ Remon, N Vilariño, N Reguart
Cancer Treatment Reviews|January 23, 2017
Leptomeningeal carcinomatosis in non-small cell lung cancer patients: A continuing challenge in the personalized treatment eraJ Remon, E Le Rhun, B Besse
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 4, 2021
Early and locally advanced non-small-cell lung cancer: an update of the ESMO Clinical Practice Guidelines focusing on diagnosis, staging, systemic and local therapyJ Remon, J-C Soria, S Peters, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 9, 2021
Malignant pleural mesothelioma: new guidelines make us stronger for defeating this diseaseJ Remon, L E L Hendriks, P Bironzo
Cancer Treatment Reviews|December 4, 2014
Malignant pleural mesothelioma: new hope in the horizon with novel therapeutic strategiesJ Remon, N Reguart, J Corral, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 21, 2018
Osimertinib and other third-generation EGFR TKI in EGFR-mutant NSCLC patientsJ Remon, C E Steuer, S S Ramalingam, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2017
A step towards the harmonization of clinical trials inform consent formsJ Remon, C Ferté
Frontiers in Oncology|April 27, 2018
Brain Metastases in Oncogene-Addicted Non-Small Cell Lung Cancer Patients: Incidence and TreatmentJ Remon, Benjamin Besse
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 21, 2017
Improving brain penetration of kinase inhibitors in lung cancer patients with oncogene dependencyJ Remon, J C Soria
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 24, 2025
Telisotuzumab vedotin and osimertinib: the METamorphosis of epidermal growth factor receptor-mutant lung cancer?J Remon, S P L Saw
Cancer Treatment Reviews|February 18, 2018
Immune checkpoint inhibitors in non-small cell lung cancer (NSCLC): Approaches on special subgroups and unresolved burning questionsJ Remon, N Vilariño, N Reguart
Cancer Treatment Reviews|January 23, 2017
Leptomeningeal carcinomatosis in non-small cell lung cancer patients: A continuing challenge in the personalized treatment eraJ Remon, E Le Rhun, B Besse
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 4, 2021
Early and locally advanced non-small-cell lung cancer: an update of the ESMO Clinical Practice Guidelines focusing on diagnosis, staging, systemic and local therapyJ Remon, J-C Soria, S Peters, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 9, 2021
Malignant pleural mesothelioma: new guidelines make us stronger for defeating this diseaseJ Remon, L E L Hendriks, P Bironzo
Cancer Treatment Reviews|December 4, 2014
Malignant pleural mesothelioma: new hope in the horizon with novel therapeutic strategiesJ Remon, N Reguart, J Corral, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 21, 2018
Osimertinib and other third-generation EGFR TKI in EGFR-mutant NSCLC patientsJ Remon, C E Steuer, S S Ramalingam, et al.
Pageof 6